Rx for Biotech

Podcast Host Chris Leidli
  • 5.0 (3)
  • BUSINESS
  • UPDATED MONTHLY
Rx for Biotech

The Rx for Biotech podcast is focused on the promise of advanced therapies and the leaders across the healthcare ecosystem bringing these innovative medicines to patients in need. The podcast features interviews with the experts who are developing advanced therapies and AI-powered health technologies including physicians, healthcare providers, patient advocates, and technology leaders. To learn more about Advanced Therapies, visit our Knowledge Base: https://www.advancedtherapiesconnect.ai/knowledge-base To find a specialist at an advanced therapy treatment center, visit our Advanced Therapy AI-powered referral tool here: https://www.advancedtherapiesconnect.ai/ To learn more about Genoplex, please visit https://www.genoplex.ai

  1. OCT 10

    How NGGT is Pioneering the Next Wave of Gene Therapies

    Next Generation Gene Therapies is developing novel gene therapies for the treatment of many rare diseases. In this podcast episode, the company's Co-Founder and Chief Operating Officer, Guang Qu, discusses how the company's dual-functional vector tech platform is being used to target many diseases.

    40 min

  2. SEP 18

    Unlocking the Power of IL-2 with Aulos CEO, Aron Knickerbocker

    Immunotherapies continue to redefine treatment for many types of cancer and one of the first immunotherapies approved and used clinically as a therapeutic is Interleukin-2, or IL-2. Aulos Bioscience is an immuno-oncology company that has developed AU-007, a potential best-in-class IL-2, that improves on many of the other IL-2 products in development. In this episode, we discuss the promise of AU-007 with President and CEO, Aron Knickerbocker. Link to Interleukin-2 review article can be found here: https://www.nature.com/articles/s41587-022-01390-3

    38 min

  3. SEP 9

    Left Behind: Addressing Health Equity for the Rare Disease Patient Community

    In this podcast episode, we discuss the importance of addressing health equity for the rare disease community with Tamar Thompson, Head of Corporate Affairs at Alexion, AstraZeneca Rare Disease. Tamar discussed her efforts to champion health policy, advocacy, equity, and awareness for rare diseases. Link to NMOSD video mentioned in episode: https://www.youtube.com/playlist?list=PLJQx_6LtucSB9GGeiWTycLm7wjK_LX0ZI

    21 min

  4. SEP 5

    Emerging Cell Therapies for Blood Cancers with Arcellx CMO, Chris Heery, MD

    In this podcast episode, we sit down with Christopher Heery, the Chief Medical Officer at Arcellx to learn about the company's pipeline and lead cell therapy, anitocabtagene autoleucel, or anito-cel, that is in development for multiple myeloma. Multiple myeloma, like lymphoma and leukemia are types of cancer that start in your blood cells.

    30 min

  5. AUG 27

    Unlocking AI In Oncology with James Zou, PhD

    In this podcast episode, Dr. James Zou, Associate Professor of Biomedical Data Science and Faculty DIrector of the AI for Health department at Stanford University, shares current use cases for AI in healthcare and oncology and discusses how we can overcome challenges with LLMs to unlock the full potential of AI.

    25 min

  6. AUG 22

    Revolutioning Patient Access: An Interview with Genoplex CTO, Shoukri Kattan

    In this episode, Genoplex Founder and CEO, Chris Leidli, and CTO, Shoukri Kattan, take a dive deep into their shared passion for health, wellness, and longevity, and explore how technology is revolutionizing patient access to advanced therapies. Chris and Shoukri discuss the groundbreaking work happening at Genoplex, including how the company's Advanced Therapy Connect digital platform is transforming the way patients connect with life-changing treatments.

    44 min

  7. AUG 14

    Building a Leading Cell Therapy Service Line with Robb Richards - Penn Medicine

    Our guest for this podcast episode is Robb Richards, Corporate Director of Cell Therapy and Transplant at University of Pennsylvania, Penn Medicine. In this episode, we discuss how Penn Medicine is working to improve patient access to cellular therapies and how technology has evolved to streamline operational and clinical workflows to enhance patient experience.

    25 min

  8. JUL 28

    How MedStack helps Health Tech companies with Compliance and Data Privacy

    Our guest for this episode is Balaji Gopalan, CEO and Co-Founder of MedStack where we discuss how MedStack's tech stack is enabling digital health start-ups to be healthcare data compliant. MedStack streamlines compliance with out-of-the-box HIPAA controls and ready-to-use privacy policies, enabling the faster and more cost-effective development of digital health applications. With built-in security controls and third-party validation, MedStack is setting new standards in healthcare technology.

    41 min
See All (59)

Ratings & Reviews

5
out of 5
3 Ratings

About

The Rx for Biotech podcast is focused on the promise of advanced therapies and the leaders across the healthcare ecosystem bringing these innovative medicines to patients in need. The podcast features interviews with the experts who are developing advanced therapies and AI-powered health technologies including physicians, healthcare providers, patient advocates, and technology leaders. To learn more about Advanced Therapies, visit our Knowledge Base: https://www.advancedtherapiesconnect.ai/knowledge-base To find a specialist at an advanced therapy treatment center, visit our Advanced Therapy AI-powered referral tool here: https://www.advancedtherapiesconnect.ai/ To learn more about Genoplex, please visit https://www.genoplex.ai

Information

  • Creator
    Podcast Host Chris Leidli
  • Years Active
    2020 - 2024
  • Episodes
    59
  • Rating
    Clean
  • Copyright
    © All rights reserved
  • Show Website
    Rx for Biotech

You Might Also Like

To listen to explicit episodes, sign in.

Stay up to date with this show

Sign in or sign up to follow shows, save episodes, and get the latest updates.
Select a country or region

Africa, Middle East, and India

Asia Pacific

Europe

Latin America and the Caribbean

The United States and Canada